ArticleNeurocritical care2026
The Framework of Policy Transition in TBI: From GCS to CBI-M.
Article in Neurocritical care, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Traditional classification of traumatic brain injury (TBI) has relied predominantly on neurological responsiveness, most notably the Glasgow Coma Scale, to stratify injury severity. While this approach has provided a common clinical language for decades, it inadequately captures the biological heterogeneity, anatomical variability, and contextual factors that shape injury trajectories and outcomes. Growing recognition of these limitations has prompted the development of multidimensional classification frameworks, including the clinical, biomarker, imaging, and modifier (CBI-M) model, designed to reflect the complex and dynamic nature of TBI. The objective is to describe a structured, implementation-science-based methodology for transitioning from traditional TBI classification to the CBI-M framework while preserving clinical continuity, data integrity, and system feasibility. We propose a phased transition methodology grounded in implementation science principles, emphasizing backward compatibility, additive integration, reproducibility, scalability, and distributed responsibility. The methodology is organized into three sequential phases: (I) mapping legacy classification elements to CBI-M domains to ensure conceptual continuity; (II) operational integration through workflow-aligned, staged adoption across the trauma care continuum; and (III) system-level embedding via electronic medical records, trauma registries, governance structures, and continuous evaluation mechanisms. Explicit attention is given to data stewardship, accountability, and longitudinal consistency. The proposed methodology provides a practical roadmap for embedding multidimensional TBI classification into routine clinical practice without disrupting existing workflows or registries. By aligning classification domains with established clinical roles and care phases, the approach minimizes documentation burden while enabling incremental adoption on the basis of institutional readiness. Governance and audit mechanisms support fidelity, comparability, and sustainability over time. Transitioning to multidimensional TBI classification requires more than conceptual validity; it demands deliberate implementation strategy. The proposed methodology offers a scalable, system-aware pathway for integrating the CBI-M framework into real-world trauma care, supporting precision-oriented classification while maintaining continuity with legacy systems. This approach provides a foundation for durable adoption, quality improvement, and future research in traumatic brain injury.
Indexed as
Identifiers
42298241What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.